Three epitope-distinct human antibodies from RenMab mice neutralize SARS-CoV-2 and cooperatively minimize the escape of mutants

Coronavirus disease 2019 (COVID-19), a pandemic disease caused by the newly emerging severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has caused more than 3.8 million deaths to date. Neutralizing antibodies are effective therapeutic measures. However, many naturally occurring mutations...

Descripción completa

Detalles Bibliográficos
Autores principales: Nie, Jianhui, Xie, Jingshu, Liu, Shuo, Wu, Jiajing, Liu, Chuan, Li, Jianhui, Liu, Yacui, Wang, Meiyu, Zhao, Huizhen, Zhang, Yabo, Yao, Jiawei, Chen, Lei, Shen, Yuelei, Yang, Yi, Wang, Hong-Wei, Wang, Youchun, Huang, Weijin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Singapore 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8290868/
https://www.ncbi.nlm.nih.gov/pubmed/34285195
http://dx.doi.org/10.1038/s41421-021-00292-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8290868/
https://www.ncbi.nlm.nih.gov/pubmed/34285195
http://dx.doi.org/10.1038/s41421-021-00292-z

Ejemplares similares